Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19107925)

  • 1. Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library.
    Denholt CL; Hansen PR; Pedersen N; Poulsen HS; Gillings N; Kjaer A
    Biopolymers; 2009 Mar; 91(3):201-6. PubMed ID: 19107925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of amino acid residues in PEPHC1 important for binding to the tumor-specific receptor EGFRvIII.
    Hansen CL; Hansen PR; Pedersen N; Poulsen HS; Gillings N; Kjaer A
    Chem Biol Drug Des; 2008 Oct; 72(4):273-8. PubMed ID: 18844673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From combinatorial chemistry to cancer-targeting peptides.
    Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
    Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a novel small peptide targeted against a tumor-specific receptor.
    Campa MJ; Kuan CT; O'Connor-McCourt MD; Bigner DD; Patz EF
    Biochem Biophys Res Commun; 2000 Aug; 275(2):631-6. PubMed ID: 10964715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.
    Batra SK; Castelino-Prabhu S; Wikstrand CJ; Zhu X; Humphrey PA; Friedman HS; Bigner DD
    Cell Growth Differ; 1995 Oct; 6(10):1251-9. PubMed ID: 8845302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo identification of highly active fluorescent kappa opioid ligands from a rhodamine labeled tetrapeptide positional scanning library.
    Houghten RA; Dooley CT; Appel JR
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1947-51. PubMed ID: 15050634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
    Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
    Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity.
    Rubio-Godoy V; Ayyoub M; Dutoit V; Servis C; Schink A; Rimoldi D; Romero P; Cerottini JC; Simon R; Zhao Y; Houghten RA; Pinilla C; Valmori D
    Eur J Immunol; 2002 Aug; 32(8):2292-9. PubMed ID: 12209642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Olsen DA; Corydon T; Lorentzen KA; Knudsen HJ; Jeppesen U; Brandslund I; Jakobsen A
    Clin Cancer Res; 2008 Jun; 14(11):3278-82. PubMed ID: 18519753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel peptide agonists from a random peptide library for a 5-oxo-ETE receptor, a receptor for bioactive lipids.
    Sasaki Y; Tsujii T; Takeda S; Obinata H; Izumi T; Yamada K; Katakai R
    J Pept Sci; 2008 Dec; 14(12):1251-8. PubMed ID: 18752253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries.
    Pinilla C; Appel JR; Blanc P; Houghten RA
    Biotechniques; 1992 Dec; 13(6):901-5. PubMed ID: 1476743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional identification of novel activities: activity-based selection of proteins from complete proteomes.
    Sarkar J; Soukharev S; Lathrop JT; Hammond DJ
    Anal Biochem; 2007 Jun; 365(1):91-102. PubMed ID: 17400168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding.
    Hamzeh-Mivehroud M; Mahmoudpour A; Dastmalchi S
    Chem Biol Drug Des; 2012 Mar; 79(3):246-59. PubMed ID: 22136656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.
    Peng L; Liu R; Marik J; Wang X; Takada Y; Lam KS
    Nat Chem Biol; 2006 Jul; 2(7):381-9. PubMed ID: 16767086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combinatorial approach to the selective capture of circulating malignant epithelial cells by peptide ligands.
    Aggarwal S; Janssen S; Wadkins RM; Harden JL; Denmeade SR
    Biomaterials; 2005 Oct; 26(30):6077-86. PubMed ID: 15907998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1.
    Nagaoka T; Fukuda T; Hashizume T; Nishiyama T; Tada H; Yamada H; Salomon DS; Yamada S; Kojima I; Seno M
    J Mol Biol; 2008 Jun; 380(1):83-94. PubMed ID: 18508082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous synthesis of peptide libraries on single resin and continuous cellulose membrane supports: examples for the identification of protein, metal and DNA binding peptide mixtures.
    Kramer A; Volkmer-Engert R; Malin R; Reineke U; Schneider-Mergener J
    Pept Res; 1993; 6(6):314-9. PubMed ID: 7507364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized protocols for the isolation of specific protein-binding peptides or peptoids from combinatorial libraries displayed on beads.
    Kodadek T; Bachhawat-Sikder K
    Mol Biosyst; 2006 Jan; 2(1):25-35. PubMed ID: 16880920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF receptor variant III as a target antigen for tumor immunotherapy.
    Li G; Wong AJ
    Expert Rev Vaccines; 2008 Sep; 7(7):977-85. PubMed ID: 18767947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.